These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3015372)

  • 21. Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
    Bakowski MT; Crouch JC
    Cancer Treat Rev; 1983 Sep; 10(3):159-72. PubMed ID: 6311415
    [No Abstract]   [Full Text] [Related]  

  • 22. Etoposide and high-dose cisplatin in good-risk patients with advanced squamous cell carcinoma and adenocarcinoma of the lung.
    Ardizzoni A; Canobbio L; Pronzato P; Rubagotti A; De Palma M; Baracco F; Serrano J; Serrano S; Faravelli B; Nosenzo M
    Cancer Treat Rep; 1986 Jul; 70(7):891-2. PubMed ID: 3719580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of combination therapy with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small-cell lung cancer.
    Shin DM; Dhingra HM; Lee JS; Fossella FV; Murphy WK; Hong WK
    Am J Clin Oncol; 1992 Jun; 15(3):194-9. PubMed ID: 1317094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The efficacy and side effects of chemotherapy for primary lung cancer with cisplatin and etoposide].
    Tsutsumi T; Kawakami A; Ozawa Y; Kawaguchi H; Fujii H; Sawano T; Asamoto H
    Gan To Kagaku Ryoho; 1991 May; 18(6):1003-6. PubMed ID: 1851407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of cisplatin/etoposide and endostar for extensive-stage small-cell lung cancer.
    Zhou ZT; Zhou FX; Wei Q; Zou LY; Qin BF; Peng XS
    Cancer Chemother Pharmacol; 2011 Oct; 68(4):1027-32. PubMed ID: 21327933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination chemotherapy with vindesine, etoposide, and cisplatin in non-small cell lung cancer: a pilot study of the Southeastern Cancer Study Group.
    Hainsworth JD; Porter LL; Johnson DH; Hande KR; Wolff SN; Birch R; Enas G; Greco FA
    Cancer Treat Rep; 1986 Mar; 70(3):339-41. PubMed ID: 3955545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adriamycin, cisplatin and etoposide combination chemotherapy in non-small cell lung cancer].
    Yamaji Y; Fujita J; Kamei M; Futami H; Hashimoto Y; Bungo M; Nakamura H; Hata Y; Shiotani T; Irino S
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):601-6. PubMed ID: 1849390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vinblastine-associated pulmonary toxicity in patients receiving combination therapy with mitomycin and cisplatin.
    Hoelzer KL; Harrison BR; Luedke SW; Luedke DW
    Drug Intell Clin Pharm; 1986 Apr; 20(4):287-9. PubMed ID: 3698826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitomycin C, vinblastine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer.
    Nomura F; Shimokata K; Saito H; Sakai S; Watanabe A; Saka H
    Cancer Chemother Pharmacol; 1987; 20(4):324-6. PubMed ID: 2826032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current status in the treatment of inoperable non-small cell lung cancer (NSCLC)].
    Nishimura M; Sugiura T; Urata A; Ota K
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):54-60. PubMed ID: 2578274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903.
    Kubota K; Nishiwaki Y; Sugiura T; Noda K; Mori K; Kawahara M; Negoro S; Watanabe K; Imamura F; Tamura T; Saijo N
    Clin Cancer Res; 2005 Aug; 11(15):5534-8. PubMed ID: 16061870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A weekly cisplatin-based induction regimen for extensive non-small cell lung cancer. A Southwest Oncology Group study.
    Higano CS; Crowley J; Livingston RB; Goodwin JW; Barlogie B; Stuckey WJ
    Cancer; 1991 May; 67(10):2439-42. PubMed ID: 1849785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of combination chemotherapy with cisplatin, vincristine, doxorubicin and etoposide (Tokushima-CODE: T-CODE) against lung cancer].
    Yanagawa H; Bando H; Takishita Y; Shinohara T; Tanaka H
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1403-5. PubMed ID: 1323959
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pilot combination phase II study of mitomycin C plus cisplatin for non-small cell lung cancer].
    Shimizu E; Kamei T; Kimura K; Mukai J; Nakamura Y; Kunishige E; Fukuta K; Tani K; Sone S; Ogura T
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3719-23. PubMed ID: 2556971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antiemetic efficacy of granisetron in patients receiving 5-day continuous infusion of cisplatin].
    Takahashi T; Mori K; Suga Y; Tominaga K
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1873-5. PubMed ID: 8397491
    [No Abstract]   [Full Text] [Related]  

  • 36. Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B.
    Miller AA; Herndon JE; Hollis DR; Ellerton J; Langleben A; Richards F; Green MR
    J Clin Oncol; 1995 Aug; 13(8):1871-9. PubMed ID: 7636529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II trial of etoposide and cisplatin for refractory small cell lung cancer: a Cancer and Leukemia Group B Study.
    Graziano SL; Lee K; Propert KJ; Tinsley R; Hayes DM; Green M; Comis RL
    Med Pediatr Oncol; 1990; 18(1):22-6. PubMed ID: 2152956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancer.
    Goldhirsch A; Joss RA; Cavalli F; Sonntag RW; Brunner KW
    Med Pediatr Oncol; 1981; 9(3):205-8. PubMed ID: 6264280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide].
    Chauvergne J; Héron JF; Mayer F; Charrot-Chinet P; Toulouse C
    Bull Cancer; 1993 Jan; 80(1):70-9. PubMed ID: 7515729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chemotherapy of non-small cell bronchial cancer with ifosfamide in combination with cisplatin, etoposide or vindesine].
    Drings P; Becker H; Bülzebruck H; Djawid N; Ruchalla E; Stiefel P; Tessen HW
    Onkologie; 1988; 11 Suppl 2():47-56. PubMed ID: 2851761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.